• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

ACITRETIN Drug Record

  • Summary
  • Interactions
  • Claims
  • ACITRETIN chembl:CHEMBL1131 Approved

    Alternate Names:

    RO 10-1670
    SORIATANE
    ACITRETIN
    ETRETIN
    NEOTIGASON
    RO-101670000
    ACITRETINE
    ACITRETINA
    ALL-TRANS-3,7-DIMETHYL-9-(4-METHOXY-2,3,6-TRIMETHYLPHENYL)-2,4,6,8-NONATETRAENOIC ACID
    (ALL-E)-9-(4-METHOXY-2,3,6-TRIMETHYLPHENYL)-3,7-DIMETHYL-2,4,6,8-NONATETRAENOIC ACID
    ACETRETIN
    SORIATANE®
    ACITRETINUM
    chembl:CHEMBL1131
    rxcui:16818
    pubchem.compound:5284513
    drugbank:00459
    chemidplus:55079-83-9

    Drug Info:

    FDA Approval 1996
    Drug Class small molecule
    Drug Indications Keratolytic Agents
    Year of Approval 1996
    Drug Class keratolytic agents
    (4 More Sources)

    Publications:

    Imming et al., 2006, Drugs, their targets and the nature and number of drug targets., Nat Rev Drug Discov
    Overington et al., 2006, How many drug targets are there?, Nat Rev Drug Discov
    Berggren Söderlund et al., 1995, Expression of human all-trans-retinoic acid receptor beta and its ligand-binding domain in Escherichia coli., Biochem. J.
    Tippmann et al., 2009, Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin., FASEB J.
    Zouboulis, Retinoids--which dermatological indications will benefit in the near future?, Skin Pharmacol. Appl. Skin Physiol.
    Hettmannsperger et al., 1992, Cytokine-stimulated human dermal microvascular endothelial cells produce interleukin 6--inhibition by hydrocortisone, dexamethasone, and calcitriol., J. Invest. Dermatol.
    Schmitt et al., 1987, Systemic administration of etretin increases epidermal interleukin I in the rat., Br. J. Dermatol.
    Orfanos et al., 1997, Current use and future potential role of retinoids in dermatology., Drugs
    Saurat, 1999, Retinoids and psoriasis: novel issues in retinoid pharmacology and implications for psoriasis treatment., J. Am. Acad. Dermatol.
    Tian et al., 1997, The isolation and characterization of purified heterocomplexes of recombinant retinoic acid receptor and retinoid X receptor ligand binding domains., Biochemistry
    Berman et al., 2000, The Protein Data Bank., Nucleic Acids Res.
  • ACITRETIN   RXRG

    Interaction Score: 1.93

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Mechanism of Interaction Retinoid receptor agonist
    Direct Interaction yes

    PMIDs:
    17016423 17139284 9074840


    Sources:
    ChemblInteractions

  • ACITRETIN   RXRB

    Interaction Score: 1.29

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Direct Interaction yes
    Mechanism of Interaction Retinoid receptor agonist

    PMIDs:
    17016423 17139284


    Sources:
    ChemblInteractions

  • ACITRETIN   RARB

    Interaction Score: 1.1

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Direct Interaction yes
    Mechanism of Interaction Retinoid receptor agonist

    PMIDs:
    7755585 19144697 11586072


    Sources:
    ChemblInteractions

  • ACITRETIN   RARG

    Interaction Score: 0.97

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Mechanism of Interaction Retinoid receptor agonist
    Direct Interaction yes

    PMIDs:
    10592235 17016423 17139284


    Sources:
    ChemblInteractions

  • ACITRETIN   RARA

    Interaction Score: 0.9

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Trial Name -
    Novel drug target Established target
    Mechanism of Interaction Retinoid receptor agonist

    PMIDs:
    10459139 19144697 9153406 9074840


    Sources:
    TdgClinicalTrial ChemblInteractions TEND

  • ACITRETIN   IL1B

    Interaction Score: 0.31

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    1431212 2954576


    Sources:
    NCI

  • ACITRETIN   STAT3

    Interaction Score: 0.17

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    TTD

  • ACITRETIN   RXRA

    Interaction Score: 0.16

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Mechanism of Interaction Retinoid receptor agonist
    Direct Interaction yes

    PMIDs:
    9153406 9074840


    Sources:
    ChemblInteractions

  • ACITRETIN   RAPGEF4

    Interaction Score: 0.09

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • ACITRETIN   KAT2A

    Interaction Score: 0.03

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • ACITRETIN   PLK1

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • ACITRETIN   USP1

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • ACITRETIN   MAPT

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • ACITRETIN   KDM4A

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • ACITRETIN   VDR

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • ACITRETIN   GMNN

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • TEND: ACITRETIN

    • Version: 01-August-2011

    Alternate Names:
    ACITRETIN Primary Drug Name

    Drug Info:
    Drug Class keratolytic agents
    Year of Approval 1996

    Publications:

  • TdgClinicalTrial: ACITRETIN

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications Keratolytic Agents
    Drug Class small molecule
    FDA Approval 1996

    Publications:

  • NCI: ACITRETIN

    • Version: 14-September-2017

    Alternate Names:
    C985 NCI drug code

    Drug Info:

    Publications:
    Hettmannsperger et al., 1992, Cytokine-stimulated human dermal microvascular endothelial cells produce interleukin 6--inhibition by hydrocortisone, dexamethasone, and calcitriol., J. Invest. Dermatol.

  • NCI: ETRETIN

    • Version: 14-September-2017

    Alternate Names:
    C985 NCI drug code

    Drug Info:

    Publications:
    Schmitt et al., 1987, Systemic administration of etretin increases epidermal interleukin I in the rat., Br. J. Dermatol.

  • TTD: Acitretin

    • Version: 2020.06.01

    Alternate Names:
    D05QDC TTD Drug ID

    Drug Info:

    Publications:

  • DTC: ACITRETIN

    • Version: 02-September-2020

    Alternate Names:
    CHEMBL1131 ChEMBL Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL1131

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

  • ChemblInteractions: CHEMBL1131

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21